Cutaneous Effects of Cryogen Spray Cooling
CSC
1 other identifier
interventional
53
1 country
1
Brief Summary
Cryogen Spray Cooling spurt is applied to the skin surface immediately before laser exposure. As liquid cryogen rapidly evaporates, the superficial skin temperature is reduced as a result of supplying the latent heat of vaporization. Tetrafluoroethane, an environmentally compatible, non-toxic, non-flammable freon substitute, has been demonstrated in multiple studies to be a safe and effective cooling agent and is the only cryogenic compound currently approved for dermatologic use by the Food and Drug Administration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1 pain
Started Jan 2004
Longer than P75 for phase_1 pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2004
CompletedFirst Submitted
Initial submission to the registry
December 19, 2007
CompletedFirst Posted
Study publicly available on registry
December 27, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2010
CompletedNovember 1, 2022
October 1, 2022
6.7 years
December 19, 2007
October 28, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Skin cooling during laser treatment
Cryogen Spray Cooling spray cooling skin during laser treatment
1 minute
Study Arms (1)
Effects of Cryogen Spray Cooling
EXPERIMENTALCutaneous Effects of Cryogen Spray Cooling
Interventions
Cutaneous Effects of Cryogen Spray Cooling
Eligibility Criteria
You may qualify if:
- Adult 18 years and older
You may not qualify if:
- Age \<18
- History of cold sensitivity
- Inflammatory rash on the test site
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beckman Laser Institute Medical and Surgical clinic
Irvine, California, 92612, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
John S Nelson, M.D.,Ph.D
Beckman Laser Institute
- PRINCIPAL INVESTIGATOR
Wangcun Jia, PhD
Beckman Laser Institute
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Wangcun Jia, PhD., Research Scientist
Study Record Dates
First Submitted
December 19, 2007
First Posted
December 27, 2007
Study Start
January 1, 2004
Primary Completion
September 1, 2010
Study Completion
September 1, 2010
Last Updated
November 1, 2022
Record last verified: 2022-10